000 | 01586 a2200457 4500 | ||
---|---|---|---|
005 | 20250513201622.0 | ||
264 | 0 | _c20000127 | |
008 | 200001s 0 0 eng d | ||
022 | _a0887-4476 | ||
024 | 7 |
_a10.1002/(SICI)1098-2396(199612)24:4<322::AID-SYN2>3.0.CO;2-F _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMach, R H | |
245 | 0 | 0 |
_aComparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomography. _h[electronic resource] |
260 |
_bSynapse (New York, N.Y.) _cDec 1996 |
||
300 |
_a322-33 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzamides _xmetabolism |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 | _aMacaca mulatta |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPiperidines _xmetabolism |
650 | 0 | 4 | _aRadioligand Assay |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Dopamine D2 _xmetabolism |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTomography, Emission-Computed |
700 | 1 | _aNader, M A | |
700 | 1 | _aEhrenkaufer, R L | |
700 | 1 | _aLine, S W | |
700 | 1 | _aSmith, C R | |
700 | 1 | _aLuedtke, R R | |
700 | 1 | _aKung, M P | |
700 | 1 | _aKung, H F | |
700 | 1 | _aLyons, D | |
700 | 1 | _aMorton, T E | |
773 | 0 |
_tSynapse (New York, N.Y.) _gvol. 24 _gno. 4 _gp. 322-33 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/(SICI)1098-2396(199612)24:4<322::AID-SYN2>3.0.CO;2-F _zAvailable from publisher's website |
999 |
_c10594139 _d10594139 |